We are excited to inform you that the miRoncol team was selected to present at the high-impact New York Venture Summit in September 2024! Hosted by youngStartup Ventures, this premier event served as a vital platform connecting VCs, angel investors, and executives from over 100 emerging tech companies. Our participation was a key strategic step, allowing us to showcase how miRoncol’s cutting-edge, Nobel-recognized microRNA (miRNA) technology is revolutionizing early cancer detection. Connecting with industry leaders and investors at this critical summit has helped us accelerate our mission to bring this groundbreaking predictive AI technology to market and transform preventative healthcare.
